Table. 1.

Table. 1.

Distribution of baseline characteristics in the group of patients undergoing radical surgery and palliative chemotherapy (percentages indicated in a vertical column)

Characteristic Radical surgery Palliative chemotherapy only p-value
Total (n) 62 172
Age (yr) 0.272
≤ 50 28 (45.2) 64 (37.2)
> 50 34 (54.8) 108 (62.8)
Sex 0.021
Male 26 (41.9) 45 (26.2)
Female 36 (58.1) 127 (73.8)
CA19.9 0.771
>15 U/L 38 (61.3) 109 (63.4)
Preoperative biliary drainage 0.191
Yes 5 (8.1) 25 (14.5)
Incidental GBC 18 (29.0) 86 (50.0) 0.004
Neoadjuvant chemotherapy 25 (40.3) 59 (34.3) 0.397
Subsite of metastatic disease < 0.001
Station 16 node 5 (8.1) 48 (27.9)
Peritoneal 9 (14.5) 97 (56.4)
Liver 2 (3.2) 17 (9.9)
N2 disease 46 (74.2) 0 (0.0)
Port/Scar site 0 (0.0) 10 (5.8)
Grade 0.084
Well differentiated 7 (11.3) 28 (16.3)
Moderately differentiated 33 (53.2) 61 (35.5)
Poorly differentiated 22 (35.5) 83 (48.2)

Values are presented as number (%).

GBC, gallbladder cancer.

Ann Hepatobiliary Pancreat Surg 2023;27:180-8 https://doi.org/10.14701/ahbps.22-111
© 2023 Ann Hepatobiliary Pancreat Surg